Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
WHIM syndrome is an immunodeficiency disease characterized by neutropenia, hypogammaglobulinemia and extensive human papillomavirus (HPV) infection. Despite the peripheral neutropenia, bone marrow aspirates from affected individuals contain abundant mature myeloid cells, a condition termed myelokathexis. The susceptibility to HPV is disproportionate compared with other immunodeficiency conditions, suggesting that the product of the affected gene may be important in the natural control of this infection. We describe here the localization of the gene associated with WHIM syndrome to a region of roughly 12 cM on chromosome 2q21 and the identification of truncating mutations in the cytoplasmic tail domain of the gene encoding chemokine receptor 4 (CXCR4). Haplotype and mutation analyses in a pedigree transmitting myelokathexis as an apparently autosomal recessive trait support genetic heterogeneity for this aspect of the WHIM syndrome phenotype. Lymphoblastoid cell lines carrying a 19-residue truncation mutation show significantly greater calcium flux relative to control cell lines in response to the CXCR4 ligand, SDF-1, consistent with dysregulated signaling by the mutant receptor. The identification of mutations in CXCR4 in individuals with WHIM syndrome represents the first example of aberrant chemokine receptor function causing human disease and suggests that the receptor may be important in cell-mediated immunity to HPV infection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Alterations in GPCR signalling are implicated in the pathogenesis and treatment of neuropsychiatric55, immunological56, gastrointestinal57,58, cardiac59, renal, hormonal, infectious60 and many other disorders53,54.”
From Unexplored therapeutic opportunities in the human genome (2018) · cites this paper as [56]
Citations
Cites
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor
Feng, Y., Broder, C. C., Kennedy, P. E., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5263.872 · Cited by 4,172
Identification of a major co-receptor for primary isolates of HIV-1
Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Marzio, P. D., Marmon, S., Sutton, R. E., Hill, C. M., et al. (1996) · Nature · doi:10.1038/381661a0 · Cited by 3,641 · cited 1×
“To date, their role in disease causation has been best established for the co-receptor function of CCR5 and CXCR4 in HIV infectio”
BackgroundParametric and nonparametric linkage analysis: a unified multipoint approach.
Kruglyak, L., Daly, M. J., Daly, M. J., & Lander, E. S. (1996) · PubMed · Cited by 2,877
Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development
Zou, Y.-R., Kottmann, A. H., Kuroda, M., Taniuchi, I., & Littman, D. R. (1998) · Nature · doi:10.1038/31269 · Cited by 2,489
Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S.-I., Kitamura, Y., Yoshida, N., Kikutani, H., & Kishimoto, T. (1996) · Nature · doi:10.1038/382635a0 · Cited by 2,338
Ma, Q., Jones, D., Borghesani, P. R., Segal, R. A., Nagasawa, T., Kishimoto, T., Bronson, R. T., & Springer, T. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9448 · Cited by 1,682
The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract
Tachibana, K., Hirota, S., Iizasa, H., Yoshida, H., Kawabata, K., Kataoka, Y., Kitamura, Y., Matsushima, K., Yoshida, N., Nishikawa, S.-I., et al. (1998) · Nature · doi:10.1038/31261 · Cited by 1,525
Multilocus linkage analysis in humans: detection of linkage and estimation of recombination.
Lathrop, M. G., Lalouel, J.-M., Julier, C., & Ott, J. (1985) · Europe PMC (PubMed Central) · Cited by 1,228
Burger, J. A., Tsukada, N., Burger, M., Zvaifler, N. J., Dell'Aquila, M., & Kipps, T. J. (2000) · Blood · doi:10.1182/blood.v96.8.2655 · Cited by 607 · cited 1×
“Moreover, CXCR4 and SDF-1 signaling has been shown to inhibit spontaneous apoptosis in human chronic lymphocytic leukemia B cell”
Background
Cited by
Items 101–200 of 724
CXCR4/CXCL12 Hyperexpression Plays a Pivotal Role in the Pathogenesis of Lupus
Wang, A., Fairhurst, A.-M., Tus, K., Subramanian, S., Liu, Y., Lin, F., Igarashi, P., Zhou, X. J., Batteux, F., Wong, D., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801920 · Cited by 125
“CXCR4 defects in humans lead to a syndrome characterized by warts, hypogammaglobulinemia, immunodeficiency, and myelokathexis, collectively termed the WHIM syndrome (9).”
BackgroundELANE Mutations in Cyclic and Severe Congenital Neutropenia
Horwitz, M. S., Corey, S. J., Grimes, H. L., & Tidwell, T. J. (2012) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2012.10.004 · Cited by 138
Host defenses against human papillomaviruses: lessons from epidermodysplasia verruciformis
Orth, G. (2008) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-75203-5_3 · Cited by 40
Schöneberg, T., & Liebscher, I. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000011 · Cited by 120
Varettoni, M., Zibellini, S., Defrancesco, I., Ferretti, V. V., Rizzo, E., Malcovati, L., Gallì, A., Porta, M. G. D., Boveri, E., Arcaini, L., et al. (2017) · Haematologica · doi:10.3324/haematol.2017.172718 · Cited by 127
“These mutations are similar to germline mutations typical of the WHIM syndrome, an inherited autosomal dominant disorder characterized by warts, hypogammaglobulinemia, infections and myelokathexis.(15) In WM, somatic CXCR4 mutations result in impaired internalization of the CXCR4 receptor, leading to constitutive acti…”
BackgroundDefining the genetic susceptibility to cervical neoplasia—A genome-wide association study
Leo, P. J., Madeleine, M. M., Wang, S., Schwartz, S. M., Newell, F., Pettersson, U., Hemminki, K., Hallmans, G., Tiews, S., Steinberg, W., et al. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006866 · Cited by 133
“Also, persistent HPV infections are associated with the two genetic conditions: epidermodysplasia verruciformis caused by mutations in the EVER1 and EVER2 genes [4], and WHIM syndrome, associated with mutations in CXCR4 [5].”
BackgroundCXCL12 and CXCR4 in bone marrow physiology
Moll, N. M., & Ransohoff, R. M. (2010) · Expert Review of Hematology · doi:10.1586/ehm.10.16 · Cited by 125
Drug Discovery Research Targeting the CXC Chemokine Receptor 4 (CXCR4)
Choi, W., Duggineni, S., Xu, Y., Huang, Z., & An, J. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200568c · Cited by 129
Human dendritic cell deficiency: the missing ID?
Collin, M. P., Bigley, V., Haniffa, M. A., & Hambleton, S. (2011) · Nature reviews. Immunology · doi:10.1038/nri3046 · Cited by 139
“The warts, hypogammaglobulinaemia, immunodeficiency and myelokathexis (WHIM) syndrome is a progressive immunodeficiency that results from mutation of CXC-chemokine receptor 4 (CXCR4), which prevents leukocytes from leaving the bone marro”
BackgroundChemokine regulation of inflammation during acute viral infection
Glass, W. G., Rosenberg, H. F., & Murphy, P. M. (2003) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/00130832-200312000-00008 · Cited by 114
CXCR4+/FLK-1+ Biomarkers Select a Cardiopoietic Lineage from Embryonic Stem Cells
Nelson, T. J., Faustino, R. S., Chiriac, A. E., Crespo‐Diaz, R. J., Behfar, A., & Terzic, A. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0808 · Cited by 114
Neutrophil Migration Under Normal and Sepsis Conditions
Lerman, Y. V., & Kim, M. (2015) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/1871529x15666150108113236 · Cited by 126
“The majority of these patients has truncation mutations in Cxcr4 and is neutropenic despite increased numbers of neutrophils in the bone marrow [34, 35].”
BackgroundHost Responses to Infection with Human Papillomavirus
Stanley, M., & Sterling, J. C. (2014) · Current problems in dermatology · doi:10.1159/000355964 · Cited by 116
Genetics of resistance to HIV infection: Role of co-receptors and co-receptor ligands
Arenzana‐Seisdedos, F., & Parmentier, M. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.07.007 · Cited by 123
WHIM Syndrome: from Pathogenesis Towards Personalized Medicine and Cure
Heusinkveld, L. E., Majumdar, S., Gao, J., McDermott, D. H., & Murphy, P. M. (2019) · Journal of Clinical Immunology · doi:10.1007/s10875-019-00665-w · Cited by 119
Genomics, Signaling, and Treatment of Waldenström Macroglobulinemia
Hunter, Z. R., Yang, G., Xu, L., Liu, X., Castillo, J. J., & Treon, S. P. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.0814 · Cited by 111
Plerixafor for the Treatment of WHIM Syndrome
McDermott, D. H., Pastrana, D. V., Calvo, K. R., Pittaluga, S., Velez, D. S., Cho, E., Liu, Q., Trout, H. H., Neves, J. F., Gardner, P. J., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1808575 · Cited by 108
Primary immunodeficiencies reveal the essential role of tissue neutrophils in periodontitis
Silva, L. M., Brenchley, L., & Moutsopoulos, N. M. (2018) · Immunological Reviews · doi:10.1111/imr.12724 · Cited by 110
Xu, H., Li, M., Gui, J., & Hong, Y. (2010) · Science China Life Sciences · doi:10.1007/s11427-010-0058-8 · Cited by 103
The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndrome
Dale, D. C., Bolyard, A. A., Kelley, M. L., Westrup, E. C., Makaryan, V., Aprikyan, A. A. G., Wood, B. L., & Hsu, F. J. (2011) · Blood · doi:10.1182/blood-2011-06-360586 · Cited by 101
New Insight Into Neutrophils: A Potential Therapeutic Target for Cerebral Ischemia
Chen, R., Zhang, X., Gu, L., Zhu, H., Zhong, Y., Ye, Y., Xiong, X., & Jian, Z. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.692061 · Cited by 120
Schmidt, J., Federmann, B., Schindler, N. M., Steinhilber, J., Bonzheim, I., Fend, F., & Quintanilla‐Martínez, L. (2015) · British Journal of Haematology · doi:10.1111/bjh.13361 · Cited by 100
Kawai, T., Choi, U., Whiting‐Theobald, N., Linton, G. F., Brenner, S., Sechler, J. M. G., Murphy, P. M., & Malech, H. L. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2005.01.001 · Cited by 103
Regulation of immune responses by neutrophils
Wang, J., & Arase, H. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12445 · Cited by 123
Ng, Y. Y., Du, Z., Zhang, X., Chng, W. J., & Wang, S. (2021) · Cancer Gene Therapy · doi:10.1038/s41417-021-00365-x · Cited by 105
Stromal derived factor 1α: A chemokine that delivers a two-pronged defence of the myocardium
Bromage, D. I., Davidson, S. M., & Yellon, D. M. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.03.009 · Cited by 97
“Similarly, in humans, CXCR4 mutation causes impaired mobilisation of neutrophils and Bcell lymphopaenia (Hernandez et al., 2003).”
BackgroundSmall Neutralizing Molecules to Inhibit Actions of the Chemokine CXCL12
Hachet-Haas, M., Balabanian, K., Rohmer, F., Pons, F., Franchet, C., Lecat, S., Chow, K. Y. C., Dagher, R., Gizzi, P., Didier, B., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803947200 · Cited by 97
Hunter, Z. R., Xu, L., Yang, G., Tsakmaklis, N., Vos, J. M. I., Liu, X., Chen, J., Manning, R. J., Chen, J. G., Brodsky, P., et al. (2016) · Blood · doi:10.1182/blood-2016-03-708263 · Cited by 115
“These somatic mutations are similar to the causal germ line variants that underlie WHIM (warts, hypogammaglobulinemia, infection, and myelokathexis) syndrome.(2,9) In WM, somatic CXCR4 mutations (CXCR4) are determinants of disease presentation, as well as resistance to ibrutinib.”
BackgroundChemokine Receptor Signaling and the Hallmarks of Cancer
Lacalle, R. A., Blanco, R., Carmona‐Rodríguez, L., Martín‐Leal, A., Mira, E., & Mañes, S. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.09.011 · Cited by 103
Role of CXCL12 and CXCR4 in the pathogenesis of hematological malignancies
Peled, A., Klein, S., Beider, K., Burger, J. A., & Abraham, M. (2018) · Cytokine · doi:10.1016/j.cyto.2018.02.020 · Cited by 102
Discovery and Characterization of an Endogenous CXCR4 Antagonist
Zirafi, O., Kim, K.-A., Ständker, L., Mohr, K. B., Sauter, D., Heigele, A., Kluge, S. F., Wiercinska, E., Chudziak, D., Richter, R., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.061 · Cited by 102
“Deregulation of CXCR4/ CXCL12 signaling is associated with numerous pathological conditions, including various types of cancers, chronic inflammatory diseases, cardiovascular diseases, and immunodeficiencies (Gonzalo et al., 2000; Nanki et al., 2000; Müller et al., 2001; Hernandez et al., 2003; Wen et al., 2012).”
BackgroundInfluentialPotential of CXCR4 antagonists for the treatment of metastatic lung cancer
Burger, J. A., Stewart, D. J., Wald, O., & Peled, A. (2011) · Expert Review of Anticancer Therapy · doi:10.1586/era.11.11 · Cited by 106
Primary immunodeficiencies predisposed to Epstein‐Barr virus‐driven haematological diseases
Parvaneh, N., Filipovich, A. H., & Borkhardt, A. (2013) · British Journal of Haematology · doi:10.1111/bjh.12422 · Cited by 110
“The warts, hypogammaglobulinaemia, immunodeficiency and myelokathexis (WHIM) syndrome is a progressive immuno- deficiency that results from mutation of CXC-chemokine receptor 4 (CXCR4), which prevents leucocytes from leaving the bone marrow (Hernandez et al, 2003).”
BackgroundFadini, G. P., Ciciliot, S., & Albiero, M. (2016) · Stem Cells · doi:10.1002/stem.2445 · Cited by 97
Regulation of neutrophil trafficking from the bone marrow
Day, R. B., & Link, D. C. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0870-8 · Cited by 103
Genetic, Clinical, and Laboratory Markers for DOCK8 Immunodeficiency Syndrome
Davis, J. C., Dove, C. G., & Su, H. C. (2010) · Disease Markers · doi:10.1155/2010/972591 · Cited by 93
Neutrophil Elastase Inhibitors and Chronic Kidney Disease
Bronze-da-Rocha, E., & Santos‐Silva, A. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.26111 · Cited by 104
“CXCR4 autosomal dominant mutations are associated with WHIM syndrome, characterized by hypogammaglobulinemia, immunodeficiency and accumulation of mature, often hypersegmented or dysplasic neutrophils in the BM (myelokathexis) [12, 37].”
BackgroundSmit, M. J., Schlecht‐Louf, G., Neves, M., van den Bor, J., Penela, P., Siderius, M. H., Bachelerie, F., & Mayor, F. (2020) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023340 · Cited by 96
Fistonich, C., Zehentmeier, S., Bednarski, J. J., Miao, R., Schjerven, H., Sleckman, B. P., & Pereira, J. P. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20180778 · Cited by 91
“To address this question, we overexpressed the R334X desensitization mutant form of CXCR4 that causes WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome (Gorlin et al., 2000; Hernandez et al., 2003; Balabanian et al., 2005) in HSCs isolated from RAG2: GFP mice and reconstituted lethally irradi…”
MethodThe Regulatory Effects of Interleukin-4 Receptor Signaling on Neutrophils in Type 2 Immune Responses
Egholm, C., Heeb, L. E. M., Impellizzieri, D., & Boyman, O. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02507 · Cited by 103
Metagenomic Discovery of 83 New Human Papillomavirus Types in Patients with Immunodeficiency
Pastrana, D. V., Peretti, A., Welch, N. L., Borgogna, C., Olivero, C., Badolato, R., Notarangelo, L. D., Gariglio, M., FitzGerald, P. C., MCINTOSH, C. E., et al. (2018) · mSphere · doi:10.1128/mspheredirect.00645-18 · Cited by 99
“Vaginal washes from six individuals were pooled. dSwabs from all 18 patients were pooled into a single sample.”
BackgroundInfluentialBritton, C., Poznansky, M. C., & Reeves, P. (2021) · The FASEB Journal · doi:10.1096/fj.202001273r · Cited by 95
Severe Viral Infections and Primary Immunodeficiencies
Dropulic, L. K., & Cohen, J. I. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir610 · Cited by 89
“Hernandez et al [19] CXCR4/chemokine receptor 4 WHIM syndrome Recurrent sinopulmonary bacterial infections; chronic cutaneous and genital warts Neutropenia (neutrophil count ,500 cells/lL) With or without decreased IgG and IgA but normal IgM levels; normal antibody responses to vaccination; normal T-lymphocyte subsets…”
BackgroundLiu, Q., Chen, H., Ojode, T., Gao, X., Anaya‐O’Brien, S., Turner, N., Ulrick, J., DeCastro, R. M., Kelly, C., Cardones, A. R., et al. (2012) · Blood · doi:10.1182/blood-2011-12-395608 · Cited by 102
“2B).(12,13,38) The predicted C-terminal amino acid sequences caused by all the reported mutations in WHIM syndrome are listed in Fig.”
BackgroundInfluentialModulation of chemokine receptor activity through dimerization and crosstalk
Salanga, C. L., O’Hayre, M., & Handel, T. M. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8666-1 · Cited by 102
Sobolik, T., Su, Y., Wells, S., Ayers, G. D., Cook, R. S., & Richmond, A. J. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e13-07-0360 · Cited by 94
Human papilloma virus (HPV) infection in children and adolescents
Mammas, I., Sourvinos, G., & Spandidos, D. A. (2008) · European Journal of Pediatrics · doi:10.1007/s00431-008-0882-z · Cited by 107
“Specific cutaneous types are also detected in epidermodysplasia verruciformis, a rare familial disorder that is related to the development of large cutaneous warts that can progress to skin cancer [28], and WHIM syndrome, a rare combined immunodeficiency syndrome which is characterized by warts, hypogammaglobulinemia,…”
BackgroundCXCR4 as biomarker for radioresistant cancer stem cells
Trautmann, F., Cojoc, M., Kurth, I., Mélin, N., Bouchez, L. C., Dubrovska, A., & Peitzsch, C. (2014) · International Journal of Radiation Biology · doi:10.3109/09553002.2014.906766 · Cited by 97
“Moreover, CXCR4 is involved in cerebellar development and mediates hippocampal neuron survival (Zou et al. 1998, Lu et al. 2002), and CXCR4 mutations are associated with the WHIM (warts, hypogammaglobulinemia, infections, and myelocathexis) syndrome (Hernandez et al. 2003).”
BackgroundSavage, S. A., & Dufour, C. (2017) · Seminars in Hematology · doi:10.1053/j.seminhematol.2017.04.004 · Cited by 89
Levy, E. R., Reger, R. N., Segerberg, F., Lambert, M., Leijonhufvud, C., Baumer, Y., Carlsten, M., & Childs, R. W. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01262 · Cited by 89
“Importantly, the observation that CXCR4 expression was not substantially more intense on NK cells expanded from WHIM patients compared to healthy controls suggest the improved BM homing capacity of these NK cells is related to augmented intracellular signaling previously shown to occur with the CXCR4R334X receptor (39…”
BackgroundTsioumpekou, M., Krijgsman, D., Leusen, J. H. W., & Olofsen, P. A. (2023) · Cells · doi:10.3390/cells12151981 · Cited by 107
“Activating mutations of CXCR4 are also found in humans, resulting in neutrophil accumulation in the bone marrow and neutropenia in the circulation, in a disease known as WHIM syndrome [18].”
BackgroundDipeptidyl Peptidase-4 Regulation of SDF-1/CXCR4 Axis: Implications for Cardiovascular Disease
Zhong, J., & Rajagopalan, S. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00477 · Cited by 83
“Loss-of-function CXCR4 mutations in humans also causes impaired neutrophil mobilization and B-cell lymphopenia (51).”
BackgroundDevelopment of novel CXCR4-based therapeutics
Peled, A., Wald, O., & Burger, J. A. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.656197 · Cited by 91
“WHIM mutations potentiate CXCR4 signaling and thereby increase the retention of neutrophils within the bone marrow, causing severe neutropenia and affecting T-cell function [147,148].”
BackgroundThe good and bad faces of the CXCR4 chemokine receptor
Teixidó, J., Martínez‐Moreno, M., Díaz‐Martínez, M., & Sevilla‐Movilla, S. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.12.018 · Cited by 93
Deciphering Genetic Disease in the Genomic Era: The Model of GnRH Deficiency
Sykiotis, G. P., Pitteloud, N., Seminara, S. B., Kaiser, U. B., & Crowley, W. F. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000288 · Cited by 81
From thymus to tissues and tumors: A review of T-cell biology
Chopp, L. B., Redmond, C., O’Shea, J. J., & Schwartz, D. M. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.10.011 · Cited by 108
Kawai, T., Choi, U., Cardwell, L., Ravin, S. S. D., Naumann, N., Whiting‐Theobald, N., Linton, G. F., Moon, J., Murphy, P. M., & Malech, H. L. (2006) · Blood · doi:10.1182/blood-2006-05-025296 · Cited by 84
Arya, M., Ahmed, H. U., Silhi, N., Williamson, M. P., & Patel, H. (2007) · Tumor Biology · doi:10.1159/000102979 · Cited by 94
Emberger syndrome—Primary lymphedema with myelodysplasia: Report of seven new cases
Mansour, S., Connell, F., Steward, C. G., Østergaard, P., Brice, G. W., Smithson, S., Lunt, P. W., Jeffery, S., Dokal, I. S., Vulliamy, T., et al. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33445 · Cited by 88
“Dominant heterozygous mutations in the gene encoding CXCR4, a protein receptor with the unique ligand, CXCL12, have been associated with WHIM syndrome [Hernandez et al., 2003; Gulino et al., 2004].”
BackgroundCXCR4 mutations in WHIM syndrome: a misguided immune system?
Diaz, G. A. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00226.x · Cited by 80
“The 19-residue truncation (R334X) was recurrent in several families, including one in which an unaffected germline mosaic parent transmitted the mutation to affected offspring, providing a direct association between CXCR4 truncations in hematologic tissue and disease (22).”
BackgroundInfluentialBobkov, V., Zarca, A. M., Hout, A. V., Arimont, M., Doijen, J., Bialkowska, M., Toffoli, E. C., Klarenbeek, A., van der Woning, B., van der Vliet, H. J., et al. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.10.014 · Cited by 83
Cell circuits and niches controlling B cell development
Zehentmeier, S., & Pereira, J. P. (2019) · Immunological Reviews · doi:10.1111/imr.12749 · Cited by 90
Results of a phase 2 trial of an oral CXCR4 antagonist, mavorixafor, for treatment of WHIM syndrome
Dale, D. C., Firkin, F. C., Bolyard, A. A., Kelley, M. L., Makaryan, V., Gorelick, K. J., Ebrahim, T. M., Garg, V., Tang, W., Jiang, H. H., et al. (2020) · Blood · doi:10.1182/blood.2020007197 · Cited by 78
Leukocyte Chemoattractant Receptors in Human Disease Pathogenesis
Zabel, B. A., Rott, A., & Butcher, E. C. (2014) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104640 · Cited by 85
“Receptor expression on the cell surface does not appear to be impaired (83).”
Background2. Update on primary immunodeficiency diseases
Bonilla, F. A., & Geha, R. S. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.09.051 · Cited by 75
Pathomechanisms: homeostatic chemokines in health, tissue regeneration, and progressive diseases
Anders, H., Romagnani, P., & Mantovani, A. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.12.002 · Cited by 85
Boisson, B., Quartier, P., & Casanova, J. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.01.005 · Cited by 77
Hierarchical Organization of Multi-Site Phosphorylation at the CXCR4 C Terminus
Mueller, W., Schütz, D., Nagel, F., Schulz, S., & Stumm, R. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064975 · Cited by 74
“Consistently, mutations in the human CXCR4 gene causing small C-terminal deletions of 10 to 19 residues or a single amino acid exchange (E343K) are associated with WHIM syndrome (a rare immunodeficiency characterized by warts, hypogammaglobulinemia, infections, and myelokathexis) and gain-of-CXCR4-function [27,28,29,3…”
BackgroundEfficient Plasma Cell Differentiation and Trafficking Require Cxcr4 Desensitization
Biajoux, V., Natt, J., Freitas, C., Alouche, N., Sacquin, A., Hémon, P., Gaudin, F., Fazilleau, N., Espéli, M., & Balabanian, K. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.068 · Cited by 74
“…most WS cases were associated with a heterozygous gain-of-function mutation in the gene encoding the G-protein-coupled seven-span transmembrane receptor CXCR4, resulting in dysfunction of the signaling axis formed by CXCR4 and its chemokine CXCL12 (Balabanian et al., 2005; Hernandez et al., 2003).”
BackgroundEpidemiology of Congenital Neutropenia
Donadieu, J., Beaupain, B., Mahlaoui, N., & Bellanné‐Chantelot, C. (2013) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2012.11.003 · Cited by 73
Minina, S., Reichman‐Fried, M., & Raz, E. (2007) · Current Biology · doi:10.1016/j.cub.2007.05.073 · Cited by 74
Roten, L. T., Johnson, M. P., Forsmo, S., Fitzpatrick, E., Dyer, T. D., Brennecke, S. P., Blangero, J., Moses, E. K., & Austgulen, R. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.158 · Cited by 77
WHIM syndrome: Immunopathogenesis, treatment and cure strategies
McDermott, D. H., & Murphy, P. M. (2018) · Immunological Reviews · doi:10.1111/imr.12719 · Cited by 80
Chow, K. Y. C., Brotin, É., Khalifa, Y. B., Carthagéna, L., Teissier, S., Danckaert, A., Galzi, J., Arenzana‐Seisdedos, F., Thierry, F., & Bachelerie, F. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.11.006 · Cited by 82
Kufareva, I., Stephens, B. S., Holden, L. G., Qin, L., Zhao, C., Kawamura, T., Abagyan, R. A., & Handel, T. M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417037111 · Cited by 72
“Of note, although studying the functional importance of dimerization by coexpressing WT and nonfunctional mutant receptors is not new (27, 47, 64, 66, 67), care must be taken to ensure that the expression level of the WT receptor stays constant with increasing expression of mutant, and that the expression levels of th…”
BackgroundMultisystem multitasking by CXCL12 and its receptors CXCR4 and ACKR3
Murphy, P. M., & Heusinkveld, L. E. (2018) · Cytokine · doi:10.1016/j.cyto.2017.12.022 · Cited by 78
Role of neutrophils in ischemic heart failure
Kain, V., & Halade, G. V. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107424 · Cited by 81
Chemokine signaling in cancer: Implications on the tumor microenvironment and therapeutic targeting.
Hembruff, S. L., & Cheng, N. (2009) · PubMed · Cited by 94
The CXCR4 mutations in WHIM syndrome impair the stability of the T-cell immunologic synapse
Kallikourdis, M., Trovato, A. E., Anselmi, F., Sarukhan, A., Roselli, G., Tassone, L., Badolato, R., & Viola, A. (2013) · Blood · doi:10.1182/blood-2012-10-461830 · Cited by 83
“WHIM is associated with C-terminal, dominant mutations in the chemokine receptor CXCR4, resulting in truncation of the receptor.(4) This leads to defective recycling upon binding of the CXCR4 ligand, CXCL12, and thus increased responsiveness to CXCL12 stimulation.”
BackgroundRecent advances in the understanding of genetic defects of neutrophil number and function
Bouma, G., Ancliff, P. J., Thrasher, A. J., & Burns, S. O. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08361.x · Cited by 75
“…described in only a few patients and results from an autosomal recessively inherited general defect in fucose metabolism leading to an absence of sialyl-Lewis X (SLeX, also called CD15s) and other fucosylated ligands for selectins (Etzioni et al, 1992; Marquardt et al, 1999a; Hidalgo et al, 2003).”
BackgroundMcDermott, D. H., Lopez, J., Deng, F. M., Liu, Q., Ojode, T., Chen, H., Ulrick, J., Kwatemaa, N., Kelly, C., Anaya‐O’Brien, S., et al. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01210.x · Cited by 70
“The cause of almost all cases of WHIM syndrome is autosomal dominant inheritance of mutations in the gene encoding the chemokine receptor CXCR4, which truncate 10–19 amino acids from the C-terminus [4].”
BackgroundInfluentialTranscription factor Gfi-1 induced by G-CSF is a negative regulator of CXCR4 in myeloid cells
Sierra, M. D. L. L., Gasperini, P., McCormick, P. J., Zhu, J., & Tosato, G. (2007) · Blood · doi:10.1182/blood-2007-03-081448 · Cited by 74
WHIM syndrome: a genetic disorder of leukocyte trafficking
Gulino, A. V. (2003) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/00130832-200312000-00005 · Cited by 69
Yung, S. C., & Murphy, P. M. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00276 · Cited by 69
“For example, a form of congenital neutropenia, WHIM syndrome, arises from gain-of-function mutations truncating the C-tail of CXCR4 (Hernandez et al., 2003).”
BackgroundCXCR4 chemokine receptor antagonists: perspectives in SCLC
Burger, J. A., & Stewart, D. J. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780902804249 · Cited by 69
“Inherited heterozygous autosomal dominant mutations of the CXCR4 gene, which result in the truncation of the carboxyl terminus (C-tail) of the receptor, are associated with a rare disease known as the warts, hypogamma globulinemia, immunodeficiency and myelokathexis syndrome [46].”
BackgroundDotta, L., Notarangelo, L. D., Moratto, D., Kumar, R., Porta, F., Soresina, A., Lougaris, V., Plebani, A., Smith, C. I. E., Norlin, A.-C., et al. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.01.045 · Cited by 67
Deconstructing common variable immunodeficiency by genetic analysis
Schäffer, A. A., Salzer, U., Hammarström, L. L. G., & Grimbacher, B. (2007) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2007.04.002 · Cited by 67
Skin Manifestations of Primary Immune Deficiency
Lehman, H. K. (2013) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-013-8377-8 · Cited by 75
“Chronic papillomavirus infections are also a feature of WHIM syndrome (warts, hypogammaglobulinemia, infections, myelokathexis), which is due to a gain-offunction mutation in CXCR4 [69].”
BackgroundMonoMAC Syndrome in a Patient With a GATA2 Mutation: Case Report and Review of the Literature
Camargo, J. F., Lobo, S. A., Hsu, A. P., Zerbe, C. S., Wormser, G. P., & Holland, S. M. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit368 · Cited by 65
“CXCR4 leading to retention of mature neutrophils in the bone marrow [5]; and a more recently described immunodeficiency syndrome characterized by the presence of anti–interferon-γ”
BackgroundTassone, L., Moratto, D., Vermi, W., Francesco, M. A. D., Notarangelo, L. D., Porta, F., Lougaris, V., Facchetti, F., Plebani, A., & Badolato, R. (2010) · Blood · doi:10.1182/blood-2010-03-272096 · Cited by 65
How I treat warts, hypogammaglobulinemia, infections, and myelokathexis syndrome
Badolato, R., & Donadieu, J. (2017) · Blood · doi:10.1182/blood-2017-02-708552 · Cited by 65
“Warts, hypogammaglobulinemia, infections, andmyelokathexis (WHIM) syndrome (OMIM 193670) is a primary immunodeficiency caused by heterozygous mutations in the CXCR4 gene.(1-4) Located on chromosome 2q22, CXCR4 encodes for a G-protein–coupled chemokine receptor that is highly expressed by various stem and progenitor ce…”
BackgroundAdaptive Immunodeficiency in WHIM Syndrome
Majumdar, S., & Murphy, P. M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010003 · Cited by 67
“In WHIM syndrome, most mutations cause truncation of the C-terminus of CXCR4 and the phosphorylation sites of GRK for β-arrestin docking are no longer available, leading to reduced desensitization and prolonged signaling [8,10].”
BackgroundChemokines: key players in cancer progression and metastasis
Singh, R. (2011) · Frontiers in Bioscience-Scholar · doi:10.2741/246 · Cited by 66
“promotes formation of highly vascular tumors in mice (19, 28).”
BackgroundKallen, M. E., Dulau‐Florea, A., Wang, W., & Calvo, K. R. (2018) · Seminars in Hematology · doi:10.1053/j.seminhematol.2018.05.016 · Cited by 68
Nobiletin as a chemopreventive natural product against cancer, a comprehensive review
Chen, Y., Liang, J.-J., Wang, D.-L., Chen, J., Cao, J., Wang, Y., & Sun, C. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2030297 · Cited by 65
WHIM syndrome: A defect in CXCR4 signaling
Díaz, G. A., & Gulino, A. V. (2005) · Current Allergy and Asthma Reports · doi:10.1007/s11882-005-0005-0 · Cited by 67
Hamatake, M., Aoki, T., Futahashi, Y., Urano, E., Yamamoto, N., & Komano, J. A. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2008.00997.x · Cited by 61
McCormick, P. J., Segarra, M., Gasperini, P., Gulino, A. V., & Tosato, G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008102 · Cited by 74
“Human CXCR4 was cloned into the pPCR-Amp Script vector (Stratagene) by PCR amplification from peripheral blood of a healthy adult individual or a WHIM patient diagnosed with the previously described R334X mutation [22].”
InfluentialInfluences of rare copy-number variation on human complex traits
Hujoel, M. L. A., Sherman, M. A., Barton, A. R., Mukamel, R. E., Sankaran, V. G., Terao, C., & Loh, P. (2022) · Cell · doi:10.1016/j.cell.2022.09.028 · Cited by 68
Cervical Carcinogenesis and Immune Response Gene Polymorphisms: A Review
Mehta, A., Mooij, M., Branković, I., Ouburg, S., Morré, S. A., & Jordanova, E. S. (2017) · Journal of Immunology Research · doi:10.1155/2017/8913860 · Cited by 65
“Stronger CXCL12 induction may have similar consequences as those seen in patients with mutations in the CXCR4 gene, which lead to increased cellular responsiveness to CXCL12, yielding a rare syndrome characterised by immune deficits and extensive HPV-induced lesions [94, 95].”
Background
Metadata
- Authors
- Hernandez, P. A., Gorlin, R. J., Lukens, J. N., Taniuchi, S., Bohinjec, J., Francois, F., Klotman, M. E., & Diaz, G. A.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- University of Minnesota (US)
- Vanderbilt University (US)
- Kansai Medical University (JP)
- Ljubljana University Medical Centre (SI)
- Venue
- Nature Genetics
- Published
- 2003-04-14
- Volume
- 34
- Issue
- 1
- Pages
- 70-74
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2167070743
- Cited by
- 722
- References
- 30
- Citations by year
- 2026: 11 · 2025: 20 · 2024: 40 · 2023: 26 · 2022: 21 · 2021: 25 · 2020: 33 · 2019: 38 · 2018: 39 · 2017: 37 · 2016: 34 · 2015: 37 · 2014: 48 · 2013: 32 · 2012: 35
- FWCI
- 8.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Keywords
- WHIM syndrome, CXCR4, myelokathexis, combined immunodeficiency, neutropenia, hypogammaglobulinemia, HPV infection, calcium flux, autosomal recessive inheritance, genetic heterogeneity, cell-mediated immunity
- MeSH terms
- Agammaglobulinemia, B-Lymphocytes, Base Sequence, Chromosomes, Human, Pair 2, DNA, DNA Mutational Analysis, Female, Humans, Immunologic Deficiency Syndromes, Genetic Linkage, Male, Models, Molecular, Molecular Sequence Data, Mutation, Neutropenia, Pedigree, Warts, Receptors, CXCR4, Calcium Signaling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.